Spark Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-46,100
Closed -$5.89M 811
2018
Q3
$5.89M Hold
46,100
0.34% 86
2018
Q2
$5.22M Buy
46,100
+16,600
+56% +$1.82M 0.31% 100
2018
Q1
$3.31M Buy
+29,500
New +$3.75M 0.21% 145
2017
Q4
Sell
-3,900
Closed -$457K 815
2017
Q3
$457K Sell
3,900
-24,900
-86% -$3.18M 0.02% 499
2017
Q2
$3.74M Sell
28,800
-11,900
-29% -$1.48M 0.23% 145
2017
Q1
$5.51M Buy
40,700
+17,700
+77% +$2.68M 0.35% 64
2016
Q4
$3.3M Buy
23,000
+12,700
+123% +$1.62M 0.27% 101
2016
Q3
$1.22M Hold
10,300
0.1% 295
2016
Q2
$1.09M Hold
10,300
0.1% 288
2016
Q1
$1.15M Buy
+10,300
New +$1.3M 0.12% 276
2015
Q4
Sell
-26,700
Closed -$3.5M 857
2015
Q3
$3.5M Hold
26,700
0.46% 47
2015
Q2
$4.64M Hold
26,700
0.65% 21
2015
Q1
$4.6M Sell
26,700
-6,800
-20% -$1.04M 0.64% 19
2014
Q4
$4.34M Sell
33,500
-5,600
-14% -$722K 0.73% 12
2014
Q3
$5.03M Sell
39,100
-5,200
-12% -$536K 0.76% 10
2014
Q2
$3.92M Sell
44,300
-5,900
-12% -$567K 0.58% 29
2014
Q1
$4.72M Hold
50,200
0.73% 13
2013
Q4
$5.68M Buy
50,200
+29,200
+139% +$2.63M 0.98% 5
2013
Q3
$1.66M Hold
21,000
0.38% 62
2013
Q2
$1.38M Buy
+21,000
New +$1.35M 0.37% 72

Other funds holding UTHR

Spark Investment Management's UTHR Position: Q4 2018 in Review

Spark Investment Management sold out of United Therapeutics (UTHR) in Q4 2018, closing a stake of 46,100 shares — an estimated $5.89M sold.

Spark Investment Management first reported a position in UTHR in Q2 2013 and held it in 20 quarters. The position peaked at $5.89M in Q3 2018. 360 funds tracked by Wall St. Rank hold UTHR as of Q4 2018.

  • Spark Investment Management reported no remaining United Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Spark Investment Management sold 46,100 United Therapeutics shares in Q4 2018, an estimated $5.89M.
  • Spark Investment Management first reported a position in United Therapeutics in Q2 2013 and held it in 20 quarters.
  • Spark Investment Management's United Therapeutics position peaked at $5.89M in Q3 2018.
  • 360 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.